Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Checkpoint Therapeutics, Inc. (CKPT)  
$1.48 0.08 (5.71%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 9,550,000
Market Cap: 14.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.39 - $3.41
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Checkpoint Therapeutics is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of treatments for patients with solid tumor cancers. Co. is evaluating its primary antibody product candidate, cosibelimab, an anti-programmed death-ligand 1 antibody, in an ongoing global, open-label, multicohort clinical trial in checkpoint therapy-naive patients with selected recurrent or metastatic cancers. Co. is also evaluating its main small-molecule, targeted anti-cancer agent, olafertinib, an epidermal growth factor receptor (EGFR) inhibitor, as a potential treatment for patients with EGFR mutation-positive non-small cell lung cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 23,944 23,944 23,944 335,570
Total Sell Value $48,297 $48,297 $48,297 $531,878
Total People Sold 2 2 2 2
Total Sell Transactions 4 4 4 16
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 102
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Coronado Biosciences Inc 10% Owner   –       –       •   2024-03-20 4 A $0.00 $0 D/D 193,905 2,096,278     -
   Gray William Garrett Chief Financial Officer   •       –      –    2024-02-28 4 S $2.07 $4,212 D/D (2,035) 145,224 32%     
   Oliviero James F Iii CEO, President and Director   •       •      –    2024-02-28 4 GD $0.00 $0 D/D 9,056 341,780     -
   Oliviero James F Iii CEO, President and Director   •       •      –    2024-02-28 4 S $2.06 $12,142 D/D (5,894) 350,836 32%     
   Gray William Garrett Chief Financial Officer   •       –      –    2024-02-01 4 S $1.95 $8,024 D/D (4,115) 147,259 29%     
   Oliviero James F Iii CEO, President and Director   •       •      –    2024-02-01 4 GD $0.00 $0 D/D 12,950 356,730     -
   Oliviero James F Iii CEO, President and Director   •       •      –    2024-02-01 4 S $2.01 $23,919 D/D (11,900) 369,680 29%     
   Coronado Biosciences Inc 10% Owner   –       –       •   2023-12-29 4 A $0.00 $0 D/D 158,134 1,902,373     -
   Coronado Biosciences Inc 10% Owner   –       –       •   2023-09-25 4 A $0.00 $0 D/D 80,906 1,744,239     -
   Coronado Biosciences Inc 10% Owner   –       –       •   2023-06-30 4 A $0.00 $0 D/D 81,406 1,663,333     -
   Weiss Michael S Director   –       •      –    2023-06-13 4 A $0.00 $0 I/I 17,483 30,123     -
   Herskowitz Neil Director   –       •      –    2023-06-13 4 A $0.00 $0 D/D 17,483 35,123     -
   Salzman Barry M Director   –       •      –    2023-06-13 4 A $0.00 $0 D/D 17,483 35,123     -
   Bechon Christian Director   –       •      –    2023-06-13 4 A $0.00 $0 D/D 17,483 32,478     -
   Rosenwald Lindsay A Md Director   –       •      –    2023-06-13 4 A $0.00 $0 D/D 17,483 50,123     -
   Boilen Scott Director   –       •      –    2023-06-13 4 A $0.00 $0 D/D 17,483 37,345     -
   Oliviero James F Iii CEO, President and Director   •       •      –    2023-03-02 4 S $5.00 $27,415 D/D (5,483) 144,090 46%     
   Gray William Garrett Chief Financial Officer   •       –      –    2023-03-02 4 S $5.00 $17,955 D/D (3,591) 51,374 46%     
   Oliviero James F Iii CEO, President and Director   •       •      –    2023-02-27 4 A $0.00 $0 D/D 15,000 149,573     -
   Oliviero James F Iii CEO, President and Director   •       •      –    2023-02-27 4 S $4.65 $25,798 D/D (5,548) 134,573 46%     
   Gray William Garrett Chief Financial Officer   •       –      –    2023-02-27 4 A $0.00 $0 D/D 7,500 54,965     -
   Gray William Garrett Chief Financial Officer   •       –      –    2023-02-27 4 S $4.66 $8,919 D/D (1,914) 47,465 46%     
   Gray William Garrett Chief Financial Officer   •       –      –    2023-02-01 4 S $4.79 $15,108 D/D (3,154) 49,379 42%     
   Oliviero James F Iii CEO, President and Director   •       •      –    2023-02-01 4 S $4.77 $48,945 D/D (10,261) 182,121 42%     
   Oliviero James F Iii CEO, President and Director   •       •      –    2023-01-10 4 S $6.75 $25,761 D/D (3,817) 192,382 59%     
  102 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us